www.rttnews.com ·
Odyssey Therapeutics Prices Upsized IPO of 15 50 Mln Shares at 18 Shr
Topic context
This topic has been covered 144722 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedOdyssey Therapeutics, a biotech company, is raising capital via IPO and private placement. The proceeds will fund its operations and pipeline development. The mechanism is equity financing, not a direct product or supply chain impact. No specific drug or revenue channel is mentioned. The impact is company-specific and weak for broader sectors.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Odyssey Therapeutics upsized IPO to 15.50 million shares at $18 per share.
- Underwriters have option to purchase additional 2.33 million shares.
- Concurrent private placement of ~1.39 million shares to TPG Life Sciences Innovations at $18/share.
- Total gross proceeds expected ~$304 million.
- Stock to trade on Nasdaq under ticker ODTX starting May 8, 2026.
Related stories
upi.com
latam us Cuba sanctions
economictimes.indiatimes.com
US Stock Market Fed Split Widens as Policymakers Debate Inflation and Growth Risks
finance.yahoo.com
Shares Rally Nvidia Earnings Samsung
finance.yahoo.com
Manulife Financial Q1 Earnings Call
finance.yahoo.com